Dark Forest Capital Management’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

Dark Forest Capital Management’s Portfolio GTHX Stock Details GTHX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-8,536	Closed	-$22.9K	–	1486
2023 Q1	$22.9K	Buy	+8,536	New	+$41K	0.01%	952
2022 Q4	–	Sell	-502	Closed	-$6K	–	1556
2022 Q3	$6K	Buy	+502	New	+$5.74K	﹤0.01%	871
2022 Q1	–	Sell	-479	Closed	-$5K	–	1853
2021 Q4	$5K	Buy	479 +423	+755%	+$5.39K	﹤0.01%	1194
2021 Q3	$1K	Sell	56 -616	-92%	-$10K	﹤0.01%	1215
2021 Q2	$15K	Buy	+672	New	+$14.9K	0.01%	599

Other funds holding GTHX

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dark Forest Capital Management's GTHX Position: Q2 2023 in Review

Dark Forest Capital Management sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q2 2023, closing a stake of 8,536 shares — an estimated $22.9K sold.

Dark Forest Capital Management first reported a position in GTHX in Q2 2021 and held it in 5 quarters. The position peaked at $22.9K in Q1 2023. 80 funds tracked by Wall St. Rank hold GTHX as of Q2 2023.

Dark Forest Capital Management reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Dark Forest Capital Management sold 8,536 G1 Therapeutics, Inc. Common Stock shares in Q2 2023, an estimated $22.9K.
Dark Forest Capital Management first reported a position in G1 Therapeutics, Inc. Common Stock in Q2 2021 and held it in 5 quarters.
Dark Forest Capital Management's G1 Therapeutics, Inc. Common Stock position peaked at $22.9K in Q1 2023.
80 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q2 2023.

Based on Dark Forest Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.